Kochi, Japan

Yasuhiro Ogawa

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Kortuc Inc, Other. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuhiro Ogawa. Retrieved from https://idiyas.com/inventor/yasuhiro-ogawa-ql95awkl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 1.7

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yasuhiro Ogawa: Innovator in Cancer Treatment Technologies

Introduction

Yasuhiro Ogawa is a notable inventor based in Kochi, Japan. He has made significant contributions to the field of cancer treatment through his innovative inventions. His work focuses on enhancing the effectiveness of radiation and chemotherapy.

Latest Patents

Yasuhiro Ogawa holds a patent for a radiation/chemotherapy sensitizer designed for intratumoral local injection. This invention utilizes a hydrogel as a carrier for controlled release of hydrogen peroxide. The patent emphasizes the ability of the sensitizer to prevent the decomposition of hydrogen peroxide, thereby maintaining its effectiveness over an extended period.

Career Highlights

Ogawa is associated with Kortuc Inc., where he continues to develop groundbreaking technologies aimed at improving cancer treatment outcomes. His dedication to research and innovation has positioned him as a key figure in the medical technology sector.

Collaborations

Yasuhiro Ogawa collaborates with talented individuals such as Shiho Tokuhiro and Hideki Oda. Their combined expertise contributes to the advancement of cancer treatment technologies.

Conclusion

Yasuhiro Ogawa's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His patented technologies hold promise for improving patient outcomes and advancing therapeutic methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…